Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb, IgG1, Human Humanized, Monoclonal

Produktübersicht

• Artikelname: Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb, IgG1, Human Humanized, Monoclonal
• Artikelnummer: ABI-12-2003
• Hersteller Artikelnummer: 12-2003
• Alternativnummer: ABI-12-2003-100UG
• Hersteller: Abeomics
• Wirt: Human Humanized
• Kategorie: Antikörper
• Applikation: ELISA
• Spezies Reaktivität: Human

Produktbeschreibung

Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody, a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.

Produkteigenschaften

• Klonalität: Monoclonal
• Isotyp: IgG1
• Reinheit: Purified from cell culture supernatant by affinity chromatography

Anwendungsbeschreibung

• Application Verdünnung: ELISA 1:5000-10000, FACS 1:100